Lenacapavir oral/injection
Generic name: Lenacapavir (oral/injection)
Brand names: Sunlenca
Drug class:
Miscellaneous antivirals
Usage of Lenacapavir oral/injection
Lenacapavir is used in adults with other antiviral drugs to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Lenacapavir is not a cure for HIV or AIDS.
Lenacapavir is given after several other HIV medications did not work, have stopped working or could not be tolerated.
Lenacapavir may also be used for purposes not listed in this medication guide.
Lenacapavir oral/injection side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Lenacapavir can affect your immune system (even weeks or months after you've used lenacapavir). Tell your doctor if you have:
Common side effects of lenacapavir may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Lenacapavir oral/injection
There may be other reasons you should not use lenacapavir in combination with certain medicines, such as efavirenz, Nevirapine, rifabutin, rifampin, rifapentine, Carbamazepine, oxcarbazepine, phenytoin, primidone, Dexamethasone, prednisone, St. John's wort, phenobarbital or other barbiturate medicine.
Tell your doctor if you have ever had:
To prevent HIV in a newborn baby, use all medications to control your infection during pregnancy. Your name may be listed on an antiviral pregnancy registry.
It is not known if lenacapavir will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Women with HIV should not breastfeed. The virus can pass to your baby in your breast milk.
Relate drugs
- Baloxavir marboxil
- Bamlanivimab
- Enfuvirtide
- Fomivirsen
- Foscarnet
- Foscavir
- Fostemsavir
- Fuzeon
- Gohibic
- Ibalizumab
- Ibalizumab-uiyk
- Lagevrio
- Lenacapavir (Oral)
- Lenacapavir (Subcutaneous)
- Lenacapavir oral/injection
- Letermovir (Intravenous)
- Letermovir (Oral)
- Letermovir oral/injection
- Livtencity
- Maribavir
- Molnupiravir
- Prevymis
- Prevymis (Letermovir Intravenous)
- Prevymis (Letermovir Oral)
- Rukobia
- Sofosbuvir
- Sotrovimab
- Sovaldi
- Sunlenca
- Sunlenca (Lenacapavir Oral)
- Sunlenca (Lenacapavir Subcutaneous)
- Sunlenca oral/injection
- Tecovirimat
- Tecovirimat oral/injection
- TPOXX
- Tpoxx oral/injection
- Trogarzo
- Vilobelimab
- Vitravene
- Xofluza
How to use Lenacapavir oral/injection
Usual Adult Dose for HIV Infection:
Option 1:Initial dose:-Day 1: 927 mg suBCutaneously, 600 mg orally-Day 2: 600 mg orallyMaintenance dose:-Every 6 months (+/- 2 weeks): 927 mg subcutaneouslyOption 2:Initial dose:-Day 1: 600 mg orally-Day 2: 600 mg orally-Day 8: 300 mg orally-Day 15: 927 mg subcutaneouslyMaintenance dose:-Every 6 months (+/- 2 weeks): 927 mg subcutaneouslyUse: Treatment of human immunodeficiency virus type 1 (HIV-1) infection in heavily treatment-experienced adults having multidrug resistant HIV-1 infection unresponsive to current antiretroviral regimen due to resistance, intolerance, or safety considerations.
Warnings
Tell your doctor about all your other medicines. Some drugs should not be used with lenacapavir.
What other drugs will affect Lenacapavir oral/injection
Tell your doctor about all your current medicines. Many drugs can affect lenacapavir, especially:
This list is not complete and many other drugs may affect lenacapavir. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions